168 related articles for article (PubMed ID: 26444649)
21. Parathyroid Glands Hyperplasias Mimicking Medullary Thyroid Carcinoma Metastatic Lymph Nodes on 18F-DOPA PET/CT.
Terroir M; Grimaldi S; Hartl D; Leboulleux S; Deandreis D
Clin Nucl Med; 2019 Aug; 44(8):e497-e498. PubMed ID: 31274634
[TBL] [Abstract][Full Text] [Related]
22. Impact of FDG-PET computed tomography for surgery of recurrent or persistent differentiated thyroid carcinoma.
Weber T; Ohlhauser D; Hillenbrand A; Henne-Bruns D; Reske SN; Luster M
Horm Metab Res; 2012 Nov; 44(12):904-8. PubMed ID: 22791600
[TBL] [Abstract][Full Text] [Related]
23. [Dual-time point images of the liver with (18)F-FDG PET/CT in suspected recurrence from colorectal cancer].
Fuster D; Lafuente S; Setoain X; Navales I; Perissinotti A; Pavia J; Paredes P; Lomeña F; Pons F
Rev Esp Med Nucl Imagen Mol; 2012; 31(3):111-6. PubMed ID: 22154291
[TBL] [Abstract][Full Text] [Related]
24. Pancreatic and thyroid metastases detected with 18F-FDG PET/CT in patient with colorectal cancer.
Castillo Morales V; García Alonso P; Balsa Bretón MA; Ortega Valle A; Penín González J; Pey Illera C
Rev Esp Med Nucl Imagen Mol; 2012; 31(6):335-7. PubMed ID: 22998928
[TBL] [Abstract][Full Text] [Related]
25. Clinical value of [(18)F]FDG-PET/CT in the detection of metastatic medullary thyroid cancer.
Jiang J; Yang Z; Zhang Y; Xu X; Wang M; Hu S; Yao Z; Pan H; Zhang Y; Li D
Clin Imaging; 2014; 38(6):797-801. PubMed ID: 24973077
[TBL] [Abstract][Full Text] [Related]
26. Comparison of different positron emission tomography tracers in patients with recurrent medullary thyroid carcinoma: our experience and a review of the literature.
Treglia G; Castaldi P; Villani MF; Perotti G; Filice A; Ambrosini V; Cremonini N; Versari A; Fanti S; Giordano A; Rufini V
Recent Results Cancer Res; 2013; 194():385-93. PubMed ID: 22918771
[TBL] [Abstract][Full Text] [Related]
27. 18F NaF brain metastasis uptake in a patient with melanoma.
Jones RP; Iagaru A
Clin Nucl Med; 2014 Oct; 39(10):e448-50. PubMed ID: 24566410
[TBL] [Abstract][Full Text] [Related]
28. Imaging medullary thyroid carcinoma with persistent elevated calcitonin levels.
Giraudet AL; Vanel D; Leboulleux S; Aupérin A; Dromain C; Chami L; Ny Tovo N; Lumbroso J; Lassau N; Bonniaud G; Hartl D; Travagli JP; Baudin E; Schlumberger M
J Clin Endocrinol Metab; 2007 Nov; 92(11):4185-90. PubMed ID: 17726071
[TBL] [Abstract][Full Text] [Related]
29. [FDG PET scan of metastases in recurrent medullary carcinoma of the thyroid gland].
Szakáll S; Bajzik G; Repa I; Miklovicz T; Dabasi G; Sinkovics I; Esik O
Orv Hetil; 2002 May; 143(21 Suppl 3):1280-3. PubMed ID: 12077916
[TBL] [Abstract][Full Text] [Related]
30. Burden of metastatic bone disease measured on 18F-NaF PET/computed tomography studies as a prognostic indicator in patients with medullary thyroid cancer.
Ueda CE; Duarte PS; de Castroneves LA; Flávio J; Marin G; Sado HN; Sapienza MT; Hoff AO; Buchpiguel CA
Nucl Med Commun; 2020 May; 41(5):469-476. PubMed ID: 32187160
[TBL] [Abstract][Full Text] [Related]
31. 18F-DOPA PET/CT in Orbital Metastasis From Medullary Thyroid Carcinoma.
Ruiz JB; Orré M; Cazeau AL; Henriques de Figueiredo B; Godbert Y
Clin Nucl Med; 2016 Jun; 41(6):e296-7. PubMed ID: 27055131
[TBL] [Abstract][Full Text] [Related]
32. F-18 FDG PET imaging in gastric neuroendocrine carcinoma.
Watanabe N; Kato H; Shimizu M; Murakami J; Kawabe H; Kamisaki Y; Kageyama M; Matsunari I; Hisada K; Seto H
Clin Nucl Med; 2006 Jun; 31(6):345-6. PubMed ID: 16714897
[No Abstract] [Full Text] [Related]
33. A rare case of medullary carcinoma thyroid metastasizing to bilateral breast parenchyma.
Hassan A; Siddiqui M; Jahangir S
Nucl Med Rev Cent East Eur; 2016; 19(B):17-19. PubMed ID: 27900756
[TBL] [Abstract][Full Text] [Related]
34. FDG PET/CT of neuroendocrine carcinoma of the thyroid gland.
Zheng LC; OuYang XL; Zhang WJ; Zhang XM
Clin Nucl Med; 2015 Feb; 40(2):146-8. PubMed ID: 25546196
[TBL] [Abstract][Full Text] [Related]
35. Respective roles of thyroglobulin, radioiodine imaging, and positron emission tomography in the assessment of thyroid cancer.
Lind P; Kohlfürst S
Semin Nucl Med; 2006 Jul; 36(3):194-205. PubMed ID: 16762610
[TBL] [Abstract][Full Text] [Related]
36. Incremental diagnostic value of SPECT/CT with 131I scintigraphy after radioiodine therapy in patients with well-differentiated thyroid carcinoma.
Maruoka Y; Abe K; Baba S; Isoda T; Sawamoto H; Tanabe Y; Sasaki M; Honda H
Radiology; 2012 Dec; 265(3):902-9. PubMed ID: 23012466
[TBL] [Abstract][Full Text] [Related]
37. Utility of the PET-CT scan with (18)F-FDG in a case of choroid melanoma recurrence.
Sabate M; García JR; Valls E; Moragas M; Soler M; Riera E; Lomeña F
Rev Esp Med Nucl Imagen Mol; 2012; 31(3):167-8. PubMed ID: 22177294
[No Abstract] [Full Text] [Related]
38. Positron emission tomography (18FDG-PET) in the detection of medullary thyroid carcinoma metastases.
Mucha SA; Kunert-Radek J; Pomorski L
Endokrynol Pol; 2006; 57(4):452-5. PubMed ID: 17006852
[TBL] [Abstract][Full Text] [Related]
39. Comparison of ⁶⁸Ga-DOTATATE PET-CT, ¹⁸F-FDG PET-CT and 99mTc-(V)DMSA scintigraphy in the detection of recurrent or metastatic medullary thyroid carcinoma.
Ozkan ZG; Kuyumcu S; Uzum AK; Gecer MF; Ozel S; Aral F; Adalet I
Nucl Med Commun; 2015 Mar; 36(3):242-50. PubMed ID: 25369749
[TBL] [Abstract][Full Text] [Related]
40. Visualization of hepatic metastases of medullary thyroid carcinoma on Tc-99m MDP bone scintigraphy.
Ali I; Johns W; Gupta SM
Clin Nucl Med; 2006 Oct; 31(10):611-3. PubMed ID: 16985365
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]